FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...